Differential gene expression modulated by the cytoplasmic domain of FcγRIa (CD64) α-chain

Journal of Immunology

Volumn 173, Issue 10, 2004, Pages 6211-6219

  Qin, Hongwei ^a   Edberg, Jeffrey C ^a   Gibson, Andrew W ^a   Page, Grier P ^b   Teng, Lihong ^a   Kimberly, Robert P ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; FC GAMMA RECEPTOR IA ALPHA; FC RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKOCYTE SPECIFIC PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE INHIBITORY CYTOKINE 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CROSS LINKING; CYTOPLASM; DELETION MUTANT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENOME; INTRACELLULAR TRANSPORT; LIGAND BINDING; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; RNA STABILITY; STIMULATION; TRANSCRIPTION REGULATION;

EID: 8444224954     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.10.6211     Document Type: Article

References (44)

1. Ravetch, J. V. 1997. Fc receptors. Curr. Opin. Immunol. 9:121.
2. Lamm, M. E. 1997. Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 51:311.
3. Monteiro, R. C., and J. G. Van De Winkel. 2003. IgA Fc receptors. Annu. Rev. Immunol. 21:177.
4. McKenzie, S. E., and A. D. Schreiber. 1998. Fcγ receptors in phagocytes. Curr. Opin. Hematol. 5:16.
5. Deo, Y. M., R. F. Graziano, R. Repp, and J. G. van de Winkel. 1997. Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies. Immunol. Today 18:127.
6. Daeron, M. 1997. Structural bases of FcγR functions. Int. Rev. Immunol. 16:1.
7. Kimberly, R. P., J. Wu, A. W. Gibson, K. Su, H. Qin, X. Li, and J. C. Edberg. 2002. Diversity and duplicity; human FCγ receptors in host defense and autoimmunity. Immunol. Res. 26:177.
8. Garcia-Garcia, E., and C. Rosales. 2002. Signal transduction during Fc receptor-mediated phagocytosis. J. Leukocyte Biol. 72:1092.
9. Kinet, J. P. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17:931.
10. Launay, P., C. Patry, A. Lehuen, B. Pasquier, U. Blank, and R. C. Monteiro. 1999. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRγ association and protects against degradation of bound ligand. J. Biol. Chem. 274:7216.
11. van Vugt, M. J., M. J. Kleijmeer, T. Keler, I. Zeelenberg, M. A. van Dijk, J. H. Leusen, H. J. Geuze, and J. G. van de Winkel. 1999. The FcγRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR γ-chain. Blood 94:808.
12. Edberg, J. C., A. M. Yee, D. S. Rakshit, D. J. Chang, J. A. Gokhale, Z. K. Indik, A. D. Schreiber, and R. P. Kimberly. 1999. The cytoplasmic domain of human FcγRIa alters the functional properties of the FcγRI γ-chain receptor complex. J. Biol. Chem. 274:30328.
13. Edberg, J. C., H. Qin, A. W. Gibson, A. M. Yee, P. B. Redecha, Z. K. Indik, A. D. Schreiber, and R. P. Kimberly. 2002. The CY domain of the FcγRIa α-chain (CD64) alters γ-chain tyrosine-based signaling and phagocytosis. J. Biol. Chem. 277:41287.
14. Withoff, S., W. Helfrich, L. F. de Leij, and G. Molema. 2001. Bi-specific antibody therapy for the treatment of cancer. Curr. Opin. Mol. Ther. 3:53.
15. Keler, T., R. Graziano, A. Mandal, P. Wallace, J. Fisher, P. Guyre, M. Fanger, and Y. Deo. 1997. Bispecific antibody-dependent cellular cytotoxicily of HER2/ neu-overexpressing tumor cells by Fcγ receptor type I-expressing effector cells. Cancer Res. 57:4008.
16. V. Pullarkat, Y. D., J. Link, L. Spears, V. Marty, R. Curnow, S. Groshen, C. Gee, and J. S. Weber. 1999. A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu. Cancer Immunol. Immunother. 48:9.
17. Heijnen, I. A., and J. G. Van de Winkel. 1995. A human FcγRI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics. J. Hematother. 4:351.
18. Heijnen, I. A., L. J. Rijks, A. Schiel, B. Stockmeyer, H. H. van Ojik, M. Dechant, T. Valerius, T. Keler, A. L. Tutt, M. J. Glennie, et al. 1997. Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcγ receptor I bispecific antibodies. J. Immunol 159:5629.
19. 2+ dependence of human Fcγ receptor-initiated phagocytosis. J. Biol. Chem. 270:22301.
20. Qin, H., J. D. Moellinger, A. Wells, L. J. Windsor, Y. Sun, and E. N. Benveniste. 1998. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-α and IFN-γ. J. Immunol. 161:6664.
21. Qin, H., Y. Sun, and E. N. Benveniste. 1999. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 274:29130.
22. Zhang, H. G., K. Hyde, G. P. Page, J. P. Brand, J. Zhou, S. Yu, D. B. Allison, H. C. Hsu, and J. D. Mountz. 2004. Novel tumor necrosis factor α-regulated genes in rheumatoid arthritis. Arthritis Rheum. 50:420.
23. Drechsler, Y., S. Chavan, D. Catalano, P. Mandrekar, and G. Szabo. 2002. FcγR cross-linking mediates NF-κB activation, reduced antigen presentation capacity, and decreased IL-12 production in monocytes without modulation of myeloid dendritic cell development. J. Leukocyte Biol. 72:657.
24. Fernandez, N., M. Renedo, and M. Sanchez Crespo. 2002. FcγR receptors activate MAP kinase and up-regulate the cyclooxygenase pathway without increasing arachidonic acid release in monocytic cells. Eur. J. Immunol. 32:383.
25. Song, X., S. Shapiro, D. L. Goldman, A. Casadevall, M. Scharff, and S. C. Lee. 2002. Fcγ receptor I- and III-mediated macrophage inflammatory protein 1α induction in primary human and murine microglia. Infect. Immun. 70:5177.
26. Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540.
27. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
28. Duchemin, A. M., and C. L. Anderson. 1997. Association of non-receptor protein tyrosine kinases with the FcγRI/γ-chain complex in monocytic cells. J. Immunol. 158:865.
29. Kurosaka, K., N. Watanabe, and Y. Kobayashi. 2002. Potentiation by human serum of anti-inflammatory cytokine production by human macrophages in response to apoptotic cells. J. Leukocyte Biol. 71:950.
30. Grazia Cappiello, M., F. S. Sutterwala, G. Trinchieri, D. M. Mosser, and X. Ma. 2001. Suppression of IL-12 transcription in macrophages following Fcγ receptor ligation. J. Immunol. 166:4498.
31. Sutterwala, F. S., G. J. Noel, P. Salgame, and D. M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I. J. Exp. Med. 188:217.
32. Tridandapani, S., Y. Wang, C. B. Marsh, and C. L. Anderson. 2002. Src homology 2 domain-containing inositol polyphosphate phosphatase regulates NF-κB-mediated gene transcription by phagocytic FcγRs in human myeloid cells. J. Immunol. 169:4370.
33. Sanchez-Mejorada, G., and C. Resales. 1998. Fcγ receptor-mediated mitogen-activated protein kinase activation in monocytes is independent of Ras. J. Biol. Chem. 273:27610.
34. Ji, J. D., I. Tassiulas, K. H. Park-Min, A. Aydin, I. Mecklenbrauker, A. Tarakhovsky, L. Pricop, J. E. Salmon, and L. B. Ivashkiv. 2003. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J. Exp. Med. 197:1573.
35. Allen, J. B., H. L. Wong, G. L. Costa, M. J. Bienkowski, and S. M. Wahl. 1993. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151:4344.
36. Ohmori, Y., M. F. Smith, Jr., and T. A. Hamilton. 1996. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J. Immunol. 157:2058.
37. Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977.
38. Barnes, N., A. L. Gavin, P. S. Tan, P. Mottram, F. Koentgen, and P. M. Hogarth. 2002. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16:379.
39. Ioan-Facsinay, A., S. J. de Kimpe, S. M. Hellwig, P. L. van Lent, F. M. Hofhuis, H. H. van Ojik, C. Sedlik, S. A. da Silveira, J. Gerber, Y. F. de Jong, et al. 2002. FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16:391.
40. Gibson, A. W., J. Wu, J. C. Edberg, and R. P. Kimberly. 1998. Fcγ receptors polymorphisms: insights into pathogenesis. In Lupus: Molecular and Cellular Pathogenesis. G. M. Kammer and G. C. Tsokos, eds. Blackwell Synergy, Oxford, p. 557.
41. Moser, K. L., B. R. Neas, J. E. Salmon, H. Yu, C. Gray-McGuire, N. Asundi, G. R. Bruner, J. Fox, J. Kelly, S. Henshall, et al. 1998. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. USA 95:14869.
42. Tsao, B. P. 2000. Lupus susceptibility genes on human chromosome 1. Int. Rev. Immunol. 19:319.
43. Shai, R., F. P. Quismorio, Jr., L. Li, O. J. Kwon, J. Morrison, D. J. Wallace, C. M. Neuwelt, C. Brautbar, W. J. Gauderman, and C. O. Jacob. 1999. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum. Mol. Genet. 8:639.
44. Johanneson, B., G. Lima, J. von Salome, D. Alarcon-Segovia, and M. E. Alarcon-Riquelme. 2002. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am. J. Hum. Genet. 71:1060.